Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension

被引:36
作者
Larsson, LI [1 ]
机构
[1] Univ Uppsala Hosp, Dept Ophthalmol, S-75185 Uppsala, Sweden
关键词
D O I
10.1016/S0161-6420(01)00605-4
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the effect on intraocular pressure (IOP) over 24 hours after 4 weeks of treatment with latanoprost 0.005% and timolol gel 0.5%. Design: Randomized, open, crossover single-center study. Participants: Twenty-seven patients with ocular hypertension. Methods: The patients were randomly assigned to 4 weeks of latanoprost 0.005% once daily or timolol gel 0.5% once daily, with a 4-week washout period before switching therapy. Main Outcome Measures: Measurement of IOP during 24 hours of hospitalization. Blood pressure and heart rate were also measured repeatedly over the 24 hours. Daytime mean IOP, nighttime mean IOP, and 24-hour mean IOP were calculated as IOP area under the curve (AUC) divided by time in hours. Results: The mean IOP during daytime (7 AM to 10 PM) was 13.5 +/-0.4 mmHg (daytime IOP, AUC/15 hours, least square mean +/- standard error of the mean [SEM]) in the latanoprost group, and 14.8 +/-0.4 mmHg in the timolol gel group. This difference of 1.3 +/-0.3 mmHg was statistically significant in favor of latanoprost (P < 0.001; 95% confidence interval [Cl], 0.7, 2.0). The mean IOP at night (10 Pm to 7 AM) was 13.7<plus/minus>0.4 mmHg for latanoprost (nighttime IOP, AUC/9 hours, least square mean +/- SEM) and 15.9 +/-0.5 mmHg for timolol gel, with a difference of 2.2 +/-0.3 mmHg (P < 0.001; 95% Cl, 1.5, 2.8), At every measured time point during the 24 hours, latanoprost reduced IOP more than timolol. There was no difference between the two treatment groups regarding blood pressure and heart rate. Conclusions: Latanoprost reduced mean 24-hour IOP, mean daytime IOP, and mean nighttime IOP statistically significantly more than timolol. Also, latanoprost reduced IOP more effectively at every measured time point over the 24 hours compared with timolol gel. Ophthalmology 2001;108:1439-1444 (C) 2001 by the American Academy of Ophthalmology.
引用
收藏
页码:1439 / 1444
页数:6
相关论文
共 34 条
[1]   LATANOPROST ADMINISTERED ONCE-DAILY CAUSED A MAINTAINED REDUCTION OF INTRAOCULAR-PRESSURE IN GLAUCOMA PATIENTS TREATED CONCOMITANTLY WITH TIMOLOL [J].
ALM, A ;
WIDENGARD, I ;
KJELLGREN, D ;
SODERSTROM, M ;
FRISTROM, B ;
HEIJL, A ;
STJERSCHANTZ, J .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1995, 79 (01) :12-16
[2]   Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning - A comparison with timolol [J].
Alm, A ;
Stjernschantz, J ;
Widengard, I ;
Linden, C ;
Soderstrom, M ;
Nilsson, SE ;
Fristrom, B ;
Lindblom, B ;
Heijl, A ;
Gundersen, KG ;
Ehinger, B ;
Holmin, C ;
BengtssonStigmar, E ;
Aasved, H ;
Jangard, P ;
Ringvold, A ;
Vegge, T ;
Halseide, R ;
LundAndersen, H ;
Flesner, P ;
Thygesen, J ;
Airaksinen, J ;
Tuulonen, A .
OPHTHALMOLOGY, 1995, 102 (12) :1743-1752
[3]  
[Anonymous], ASIAN J OPHTHALMOL
[4]  
Bito L., 1992, J GLAUCOMA, V1, P193
[5]  
Bito LZ, 1996, J GLAUCOMA, V5, P127
[6]   Delayed functional loss in glaucoma - LII Edward Jackson Memorial Lecture [J].
Brubaker, RF .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 121 (05) :473-483
[7]   24-HOUR (NYCTOHEMERAL) AND SLEEP-RELATED VARIATIONS OF INTRAOCULAR-PRESSURE IN HEALTHY WHITE INDIVIDUALS [J].
BUGUET, A ;
PY, P ;
ROMANET, JP .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 117 (03) :342-347
[8]   Latanoprost, a prostaglandin analog, for glaucoma therapy - Efficacy and safety after 1 year of treatment in 198 patients [J].
Camras, CB ;
Alm, A ;
Watson, P ;
Stjernschantz, J ;
Aasved, H ;
Jangard, P ;
LundAndersen, H ;
Flesner, P ;
Soderstrom, M ;
Ehinger, B ;
Holmin, C ;
BengtssonStigmar, E ;
Heijl, A ;
Gundersen, KG ;
Airaksinen, J ;
Tuulonen, A ;
Halseide, R ;
Lindblom, B ;
Ringvold, A ;
Vegge, T ;
Linden, C ;
Nilsson, SE ;
Fristrom, B ;
Widengard, I ;
Thygesen, J ;
Green, F ;
Valenzuela, F ;
Potts, M ;
Spencer, I ;
Coakes, R ;
Reynolds, P ;
Mills, B ;
Chatterjee, A ;
Nagasubramanian, S ;
Roxburgh, S ;
Sanders, R ;
Bailey, M ;
Whyte, IF ;
Vernon, S ;
Sloper, M ;
Murray, S ;
Davey, C ;
HickmanCasey, J ;
Longstaff, S ;
Currie, Z ;
Wishart, P ;
Austin, M ;
Birch, M ;
Elkington, A ;
Luff, A .
OPHTHALMOLOGY, 1996, 103 (11) :1916-1924
[9]   Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma - A six-month, masked, multicenter trial in the United States [J].
Camras, CB ;
Cioffi, GA ;
VanBuskirk, EM ;
Fraser, J ;
Stewart, WC ;
Stewart, JA ;
Lustgarten, J ;
Schumer, RA ;
Podos, SM ;
Arroyo, M ;
Nitzberg, S ;
Ritch, R ;
Abundo, G ;
Caronia, R ;
Liebmann, J ;
Steinberger, D ;
Krupin, T ;
Rosenberg, LF ;
Ruderman, JM ;
Clarkson, K ;
Weinreb, RN ;
Ochabsi, R ;
Sherwood, M ;
Smith, MF ;
Stokes, DW ;
Zam, ZS ;
Wilensky, J ;
Hillman, D ;
Kaplan, B ;
Gates, V ;
Nail, C ;
Zimmerman, T ;
Fechtner, R ;
Fenton, R ;
Fenton, J ;
Higginbotham, EJ ;
Johnson, AT ;
PollackRundle, CJ ;
Weiss, E ;
Yablonski, ME ;
Tannenbaum, MH ;
Ibrahim, F ;
Ohia, E ;
Neely, D ;
Minckler, D ;
Heuer, D ;
Lee, P ;
Padea, M ;
Kaufman, PL ;
Heatley, GA .
OPHTHALMOLOGY, 1996, 103 (01) :138-147
[10]  
DRANCE SM, 1960, ARCH OPHTHALMOL-CHIC, V64, P494